Advertisement

Topics

The PARP Combo Race Is On: Clovis And Bristol Partner On Rubraca

13:20 EDT 31 Jul 2017 | SCRIP

Amidst excitement over the potential of PD-1/PARP inhibitor combos in multiple tumor types, Clovis signs a non-exclusive agreement to test...

      

Related Stories

 

Original Article: The PARP Combo Race Is On: Clovis And Bristol Partner On Rubraca

NEXT ARTICLE

More From BioPortfolio on "The PARP Combo Race Is On: Clovis And Bristol Partner On Rubraca"

Quick Search
Advertisement
 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...